Hikal Limited (HIKAL) — Board Meeting
Hikal Limited announced the appointment of Ravi Khadabadi as President of Crop Protection & Specialty Chemicals following board approval on May 27, 2026. The filing also disclosed resolution of prior irregularities involving preponed revenue recognition, with corrective actions completed and no financial impact on current or past periods. The company emphasized adherence to SEBI disclosure norms under Regulation 30.
About Hikal Limited (HIKAL)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when HIKAL files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track HIKAL — Free💡 Ask AI about this filing
📊 More HIKAL filings
- share transfer — 9 July 2026 Hikal Limited received a confirmation certificate from MUFG Intime India Private Limited, its share ...
- Financial Results — 25 June 2026 Hikal Limited announced that its trading window will close on July 1, 2026, and remain closed until ...
- 🟡 Voting Results — 4 June 2026 Hikal Limited announced a postal ballot for shareholder approval of Mr. Sandip Parikh's appointment ...
- 🔴 Financial Results — 3 June 2026 Hikal Limited reported FY26 revenue of **₹1,713 crores** and net profit of **₹7 crores**, with EBITD...
- regulation 31 — 2 June 2026 Hikal Limited disclosed on April 6, 2026, that Kalyani Investment Company Limited and BF Investment ...
🔥 Also filed on 27 May 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when HIKAL files new disclosures
Track HIKAL filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track HIKAL — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research